NeoGenesis Inc is a pioneer in skincare, deeply rooted in stem cell science with a legacy spanning over three decades. Founded in 1997 by Dr. Greg Maguire, the company's vision is epitomized in its revolutionary S2RM® technology. NeoGenesis collaborates with leading research facilities in the United States, fostering breakthroughs in skincare and hair care through their patented S2RM® technology. The company's dedication to advancing the field of stem cell-based therapeutics and cosmeceuticals has positioned it as a trailblazer in early-generation stem cell products. NeoGenesis' commitment to scientific excellence and innovation is evident in its approach to unlocking the regenerative potential of certified adult stem cell-released molecules—the cornerstone of their 'systems therapeutics' embodied in their products. With a focus on biotechnology, health care, and pharmaceutical industries, NeoGenesis has become synonymous with the next generation of stem cell science for skincare, impacting the lives of tens of thousands globally. As the company continues to navigate the future, its founding principles of innovation and commitment to harnessing the body's inherent healing potential remain steadfast, shaping the future of skincare through the power of stem cell science.
There is no investment information
No recent news or press coverage available for NeoGenesis Inc.